Literature DB >> 15588427

CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.

Jörg Vollmer1, Marion Jurk, Ulrike Samulowitz, Grayson Lipford, Alexandra Forsbach, Meike Wüllner, Sybille Tluk, Hanna Hartmann, Andrea Kritzler, Christian Müller, Christian Schetter, Arthur M Krieg.   

Abstract

Several classes of CpG oligodeoxynucleotides (ODNs) with different immune stimulatory profiles were recently identified: the A-, B- and C-classes. In this study, we investigated the CpG-dependent stimulation of IFN-gamma-inducible protein 10 (IP-10 or CXCL10) in different human immune cell types. CpG ODNs induced IP-10 in monocytes, pDCs and in B cells. Purified B cells as well as RPMI 8226 cells responded to CpG stimulation by IP-10 production. Treatment with exogenous IFN-alpha2b sensitized PBMCs, purified B cells as well as RPMI 8226 cells to respond more efficiently to stimulation with CpG ODNs by IP-10 production. IP-10 signaling could be directly stimulated via TLR9 in CpG-unresponsive HEK293 cells transfected with human TLR9 and an IP-10 reporter construct. Therefore, CpG-mediated IP-10 production is stimulated through IFN-alpha in cells that express the IFN-alpha receptor, a second pathway for IP-10 induction exists in TLR9-expressing B cells and pDCs where IP-10 is stimulated directly upon CpG-mediated TLR9 signaling. Our data provide a better understanding of the mechanisms through which CpG ODNs induce efficient Th1 responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588427     DOI: 10.1179/096805104225006534

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  21 in total

Review 1.  Use of defined TLR ligands as adjuvants within human vaccines.

Authors:  Malcolm S Duthie; Hillarie Plessner Windish; Christopher B Fox; Steven G Reed
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice.

Authors:  Jeffrey M Duggan; Dahui You; Jeffrey O Cleaver; Derek T Larson; R Joshua Garza; Francisco A Guzmán Pruneda; Michael J Tuvim; Jiexin Zhang; Burton F Dickey; Scott E Evans
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

3.  Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages.

Authors:  Juan Wang; Yoram Vodovotz; Liyan Fan; Yuehua Li; Zheng Liu; Rami Namas; Derek Barclay; Ruben Zamora; Timothy R Billiar; Mark A Wilson; Jie Fan; Yong Jiang
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

4.  Activation of Innate Immune Responses by a CpG Oligonucleotide Sequence Composed Entirely of Threose Nucleic Acid.

Authors:  Margaret J Lange; Donald H Burke; John C Chaput
Journal:  Nucleic Acid Ther       Date:  2018-12-11       Impact factor: 5.486

5.  CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.

Authors:  Makoto Ishii; Cory M Hogaboam; Amrita Joshi; Toshihiro Ito; Daniel J Fong; Steven L Kunkel
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

Review 6.  T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Authors:  David J Kahler; Andrew L Mellor
Journal:  Handb Exp Pharmacol       Date:  2009

7.  A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cells.

Authors:  Joseph F Porter; Stefano Vavassori; Lori R Covey
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophages.

Authors:  Ping Cen; Li Ye; Qi-Jian Su; Xu Wang; Jie-Liang Li; Xin-Qin Lin; Hao Liang; Wen-Zhe Ho
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-05       Impact factor: 2.205

Review 9.  Antiinfective applications of toll-like receptor 9 agonists.

Authors:  Arthur M Krieg
Journal:  Proc Am Thorac Soc       Date:  2007-07

10.  Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.

Authors:  Jeffrey A Martinson; Allan R Tenorio; Carlos J Montoya; Lena Al-Harthi; Carolyne N Gichinga; Arthur M Krieg; Linda L Baum; Alan L Landay
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.